We investigated ropivacaine 7.5 mg/ml in comparison with bupivacaine 5 mg/ml in patients receiving interscalene brachial plexus block (ISB) and general anaesthesia.
Some clinical studies suggest 1 that the analgesic potency of ropivacaine is similar to that of bupivacaine, while motor block is less pronounced. However, other clinical trials evaluating ropivacaine and bupivacaine at equal concentrations demonstrated comparable sensory and motor blocking properties [2] [3] [4] .
Capogna et al 5 and Polley et al 6 used up-down sequential allocation models to determine the minimum local analgesic concentration (MLAC) of ropivacaine and bupivacaine. They determined that the analgesic potency ratio of ropivacaine to bupivacaine was 0.6 for epidural analgesia in the first stage of labour.
Although the dose-response relationship between bupivacaine and ropivacaine has been extensively studied for epidural anaesthesia, the effectiveness of ropivacaine in comparison to bupivacaine for peripheral nerve blocks has been examined in only a small number of studies [7] [8] [9] [10] [11] . Regarding interscalene brachial plexus block (ISB), previous studies 7, 9 found conflicting results between ropivacaine (5-10 mg/ml) and bupivacaine 5 mg/ml in terms of onset and spread of sensory and motor block, and postoperative opioid use. Different results in previous investigations may be due to varying study designs and small sample sizes. We compared the anaesthetic properties of ropivacaine 7.5 mg/ml with bupivacaine 5 mg/ml in a study population of one hundred and twenty patients, in order to evaluate whether the finding of Capogna and colleagues of a dose response relationship of 0.6:1 for ropivacaine and bupivacaine was also valid for a peripheral nerve block such as ISB. physical status 1-3) who were scheduled to undergo major shoulder surgery and had given informed consent were included in this randomized, double-blind clinical trial. Patients with a history of allergy to local anaesthetics and general contraindications to performing interscalene plexus block anaesthesia were excluded.
The patients were randomly assigned to two groups on the basis of the local anaesthetic to be utilized (ropivacaine-group=RoG or bupivacaine-group= BuG). Prior to surgery all patients were orally premedicated with midazolam (3.75 to 7.5 mg). Interscalene brachial plexus block (Needle: "Contiplex D", Braun Inc., Melsungen, Germany) was performed using a peripheral nerve stimulator ("Stimuplex HNS11", Braun Inc., Melsungen, Germany) according to the technique described by Meier 12 . After insertion of the catheter, 30 ml of the study drug (both provided by AstraZeneca Int.) was injected as a bolus. If the developing block seemed incomplete (sensory block of less than three dermatomes after 25 minutes or a missing sensory block of the upper arm region in the C5 dermatome), the patient was excluded from the study and registered as an unsuccessful block.
Evaluation of sensory and motor function began five minutes after administration of the local anaesthetic. Sensory block was assessed using pinprick in the C4 through T1 dermatomes. Assessment of motor function used a scale introduced by Simon in 1997 13 . This scale was originally developed to describe loss of motor function in patients receiving intravenous regional anaesthesia of the upper extremity and therefore had to be modified for our purposes: grade 0=no motor block, grade 1=no shoulder elevation, grade 2=no elbow flexion, grade 3=no forearm pronation/supination, grade 4=no finger movement.
Evaluation of sensory and motor block was carried out at 5, 10, 15, 20, 30 and 40 minutes. General anaesthesia was then induced intravenously with thiopentone 5 mg/kg, fentanyl 2 µg/kg and cis-atracurium 0.15 mg/kg and maintained with sevoflurane (<1.0 minimum alveolar concentration (MAC) in air).
Parameters evaluated during surgery included requirement for local anaesthetic, opioid and neuromuscular blocking drug. The administration of additional doses of local anaesthetic and opioid was standardized using clinical criteria. A 10 ml bolus of study drug was administered via the interscalene catheter if systolic arterial pressure (as judged by systolic arterial pressure) increased more than 30 % above baseline during surgery. If pain control was not successful in 10 minutes, additional intravenous fen-tanyl was administered until systolic arterial pressure returned to baseline values. In order to avoid the cardiovascular effects of inadequate relaxation, neuromuscular block was monitored continuously to achieve a train-of-four response ≤1 twitch. Patients were also monitored continuously for changes in heart rate, rhythm and arterial oxygen saturation.
Prior to surgery all patients were familiarized with a 100 mm horizontal visual analog scale (VAS). Intensity of pain and evaluation of sensory and motor function were assessed 30 minutes and 6 hours after arrival in the recovery room.
Data are expressed mainly as mean±SD. Data were analysed for equality of variances using the Kolmogorov-Smirnov test. Continuous variables were tested using the Mann-Whitney U test, binary variables were analysed with the Chi squared test or Fisher's exact test. A P value of < 0.05 was considered to represent statistical significance.
RESULTS
There was technical failure of the ISB in eight and an incomplete sensory block in 11 patients (RoG: n=5, BuG: n=6, less than three blocked dermatomes in 10 cases and incomplete block of the C5 dermatome in one case). One hundred and one patients were analysed. There were no differences in demographic values between the groups (Table 1 ) or in regard to character and duration of the surgical intervention ( Table 2) .
Sensory and motor block
The onset and development of sensory block is represented in Figure 1 . Development of sensory block was similar. Forty minutes after injection of the study drugs we found a nearly complete sensory block in all brachial dermatomes ( Table 3 ). The development and quality of motor block also was nearly identical for both local anaesthetics. At the final evaluation time (40 minutes after the block) motor paralysis reached a mean of 3.4 for both study drugs ( Figure 2 ).
Requirement for local anaesthetic and opioid
There were no differences between the groups for mean local anaesthetic volumes used, but by necessity of the study design there was a significant difference (P<0.01) in dose (Table 4 ). In the bupivacaine group the frequency of extra doses was not significantly higher (33.3% versus 26.4% with ropivacaine). There was no difference in requirement for neuromuscular blocking drug or opioid ( and 6 hours after arrival in the recovery room are displayed in Figure 3 . None of the parameters assessed to evaluate the decline of sensory block were significantly different, nor was the frequency of anaesthetized dermatomes or the number of patients with sensory block relevant to shoulder surgery (dermatomes C5, C6, sometimes T1). There were no differences between groups with respect to recovery of motor function. Thirty minutes after arrival in the recovery room the mean VAS score in RoG was 20±24 compared with 23±27 in BuG (P=NS). Three patients in RoG and one patient in BuG required supplemental administration of nonsteroidal anti-inflammatory drugs (NSAIDs) because of insufficient pain relief from ISB during the first two postoperative hours. Mean pain scores in both study groups remained almost unchanged 6 hours later (17±21 in RoG and 24±26 in BuG, P=NS). At this time 32% of RoG and 22% of BuG required additional pain medication (P=NS).
DISCUSSION
This study has demonstrated that both ropivacaine 7.5 mg/ml and bupivacaine 5 mg/ml are effective local anaesthetics for interscalene brachial plexus anaesthesia, with 84% of the blocks successful. Our results correspond to those of Hickey et al 11 who reported effective anaesthesia in 87% of dermatomes using ropivacaine 5 mg/ml.
In terms of onset and quality of sensory and motor block, ropivacaine 7.5 mg/ml was indistinguishable from bupivacaine 5 mg/ml in our investigation, although because of the study design there was a significant difference in the drug dose used. The ratio of total mean dose used (175 mg versus 259 mg, 0.67) was the same as the study concentration ratio compared, namely 5 mg/ml to 7.5 mg/ml. This suggests that the additional boluses did not affect the results and that equipotent doses were selected.
However, in the present study haemodynamic responses were used to prompt the administration of additional local anaesthetic. Because haemodynamic values might not be satisfactory indicators of depth of anaesthesia and pain intensity, this may have influenced the results in terms of drug consumption. The neuroendocrine response might have been an alternative guide but assessment of stress hormones is not feasible as a means of determining drug administration. Sensory evoked potentials (SEP), brainmapping and neuro-imaging are designed to control depth of general anaesthesia rather than pain and are also not a practical alternative in routine clinical use. To our knowledge there is no suitable means of measurement other than haemodynamic values to evaluate pain or the efficacy of pain therapy among patients under general anaesthesia.
Our results can only partially be compared with other investigations. Casati et al 7, 14 found that ropivacaine 5 mg/ml has clinical properties similar to those of bupivacaine 5 mg/ml, whereas ropivacaine 10 mg/ml and 7.5 mg/ml have an onset time to surgical anaesthesia 65% and 46% shorter than ropivacaine 5 mg/ml. However, Casati et al 7 injected a smaller local anaesthetic volume (20 ml) than usually used for ISB. They stated that the use of small volumes may have emphasized the differences between bupivacaine and ropivacaine, because the injected volume is an important factor affecting the success rate of peripheral nerve blockade [15] [16] [17] . Klein et al 9 used 30 ml but added adrenaline 1:400 000 and did not find any difference between bupivacaine 5 mg/ml, ropivacaine 5 mg/ml and ropivacaine 7.5 mg/ml. These investigators considered that their sample size (21-24 patients in each group) was too small to detect subtle differences, especially in analgesic duration. In order to detect a 30% difference in effect between the local anaesthetics about 25 patients in each group would have been necessary according to a power analysis based on an α of 0.05 and β of 0.1 18 . In the current study we tried to avoid this problem by injecting local anaesthetic volumes sufficient for routine surgical procedures and by use of a larger sample size. Klein of arm abduction. They did no further monitoring and this method might be less efficient in patients with pre-existing degenerative or traumatic shoulder lesions. Likewise Casati et al 7 only tested loss of motor function of the upper arm muscles. We investigated onset and spread of motor block using a modified "Simon Scale", corresponding to the "Bromage Scale", which is designed to evaluate motor blockade of the lower extremities, and were able to perform a more detailed evaluation of motor block from our study drugs.
In a number of comparable investigations, brachial plexus block was not achieved by the interscalene approach but by alternative techniques such as an axillary brachial plexus 19 or a subclavian perivascular approach 11 . Although it seems likely, it is not possible to be sure if the results of these studies apply to ISB, because one of the factors influencing onset and spread of local anaesthetics is the site of injection 20 .
Similar to the results in terms of spread, we found no difference in the decline of sensory and motor block between ropivacaine and bupivacaine during the first 10 hours after ISB, but cannot comment further on duration of anaesthesia. Our results correspond with those of other investigators 9 in terms of pain control. Both drugs provided good pain control in the recovery room and the need for supplementary analgesia was low.
Several authors recommend ISB as the sole anaesthetic technique for shoulder surgery because of advantages such as better haemodynamic stability in a "beach chair position" [21] [22] [23] . Nevertheless, there are some reasons to combine ISB with general anaesthesia. Ipsilateral hemidiaphragmatic paresis is a common side-effect of ISB [24] [25] [26] [27] and may lead to acute respiratory failure in patients who are breathing spontaneously [28] [29] [30] . In addition, in a small number of cases ISB fails to provide complete sensory block and general anaesthesia may have to be induced after surgery has started. This is an uncomfortable situation for both the patient and the anaesthetist.
General anaesthesia may have had an influence of some parts of the study. It is unlikely to have influenced the development and decline of sensory and motor block but may have affected the overall consumption of opioid and local anaesthetic. Nevertheless, randomization and specified conditions for additional intraoperative use of opioid and local anaesthetic should have avoided any effect on the comparison of the study drugs.
We did not find any side-effects as a result of the administration of the local anaesthetics in either group and there were no cardiovascular complications clinically after a mean dose of ropivacaine of 3.36 mg/kg. Ropivacaine has advantages in comparison to bupivacaine with respect to cardiotoxicity [31] [32] [33] [34] [35] . Although these local anaesthetics have been compared previously, we thought it important to estimate dose-response relationships under various clinical conditions. This should assist the anaesthetist in gauging appropriate dosing for satisfactory anaesthetic block on the one hand and toxicity on the other hand.
In conclusion, in this study ropivacaine 7.5 mg/ml and bupivacaine 5 mg/ml proved to be similar in terms of sensory and motor block for ISB. We found no significant differences in regard to onset, quality and efficacy of the block or the frequency of sideeffects. These findings support Capogna et al who determined a 0.6:1 potency relationship between ropivacaine and bupivacaine.
